Expression and Interactions Between Cell Adhesion Molecules CD44v6 and E-Cadherin in Human Gliomas

Area of Science:

• Neuro-oncology
• Molecular pathology
• Cancer biology

Background:

• Gliomas are heterogeneous tumors with varying behavior and infiltrative growth.
• Understanding molecular markers is crucial for predicting glioma aggressiveness.

Purpose of the Study:

• To evaluate CD44v6 and E-cadherin expression in gliomas.
• To correlate their expression with glioma malignancy grade.
• To determine the biological significance of simultaneous CD44v6 and E-cadherin expression.

Main Methods:

• Immunohistochemistry (IHC) was used to assess CD44v6 and E-cadherin expression.
• Ninety-two formalin-fixed paraffin-embedded glioma tissues were analyzed.
• Expression levels were correlated with glioma malignancy grades (I-IV).

Main Results:

• CD44v6 expression was detected in 71.6% of gliomas and significantly correlated with higher malignancy grades (p=0.001).
• E-cadherin was observed in 28.8% of gliomas, with re-expression in 43.3% of grade II gliomas, but no overall grade correlation.
• A positive correlation was found between CD44v6 and E-cadherin expression (p=0.004), though simultaneous expression did not significantly differ by grade.

Conclusions:

• CD44v6 expression is associated with glioma tumor cell malignancy.
• E-cadherin levels may reflect distinct biological features of gliomas.
• Co-expression of CD44v6 and E-cadherin in low-grade gliomas suggests a role in enhancing cell migration and invasive growth.